跳至主要内容
临床试验/ACTRN12623000348651
ACTRN12623000348651尚未招募Unknown

Behavioural Activation for negative symptoms in people with schizophrenia

SA/NT Regional Clinical Trial Coordinating Centre (SA/NT RCCC)0 个研究点目标入组 60 人开始时间: 2023年4月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The study will comprise two groups of participants: Mental health workers and consumers with a diagnosis of schizophrenia with negative symptoms.
  • (a)Mental health workers
  • Mental health workers employed by the Flinders and Upper North, Limestone Coast, and Riverland and Coorong Local Health Networks of South Australia who complete the online training in BA and agree to participate in the study. The mental health workers may include but are not limited to, mental health nurses, social workers, support workers, and occupational therapists.
  • (b)Consumers with mild-to-moderate negative symptoms as determined using the Positive and Negative Symptom scale.
  • (i)Are aged 18 years or above.
  • (ii)Are receiving a mental health service from the three participating mental health sites established for the Flinders and Upper North, Limestone Coast, and the Riverland, and Coorong Local Health Networks.
  • (iii)Are experiencing mild to moderate negative symptoms [greater than 3 on at least two negative symptom items from the Positive and Negative Syndrome Scale (PANSS).
  • (iv)Understand, read, write, and speak English.
  • (v)Provide informed consent.

排除标准

  • (a)Mental health workers
  • Mental health workers that have not completed BA training even though they may be providing mental health care service at any of the three Local Health Networks in rural South Australia.
  • (b)Consumers
  • (i)Have depressive symptoms and achieve a baseline score of 15+ on the PHQ-9 scale or acute depression and need to be seen by a psychiatrist. These people will be excluded from the study for their safety.
  • (ii)Express suicidal ideation or are at risk of self-harm, suicide, homicide, or present a risk to others. These potential participants will be referred to a general practitioner or mental health professional for support.
  • (iii)Have multiple mental health diagnoses.
  • (iv)Have a disorder that impedes effective communication (eg, severe sensory impairment) or experience difficulty understanding or communicating effectively in English, and interpretation services are not available.
  • (v)Are assessed by mental health workers as being incapable of giving informed consent to participate in the study due to their medical circumstances.

研究者

发起方
SA/NT Regional Clinical Trial Coordinating Centre (SA/NT RCCC)

相似试验